| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.018 | 0.8 |